Table 1
Results of the comparison between the gastric cardiac hyperplasia group and those without cardiac hyperplasia
| Hyperplasia (n=31) | No hyperplasia (n=276) | |
|---|---|---|
| **p < 0.01. | ||
| CI, confidence interval; GORD, gastro-oesophageal reflux disease; IM, intestinal metaplasia; NSAID, non-steroidal anti-inflammatory drug. | ||
| Mean age (years, 95% CI) | 55 (49 to 60) | 53 (51 to 55) |
| Male : female ratio | 1 : 1.2 | 1 : 1.8 |
| NSAID use | 19% | 19% |
| Cardia incomplete IM | 13% | 7% |
| Cardia complete IM | 26% | 9%** |
| Carditis | 77% | 48%** |
| Endoscopy positive GORD | 19% | 14% |
